ARCHIVES

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

November 24, 1978

In Brief: “The Journal” to Mae its Appearance In Jan., With Wittes As Editor; Manuscripts Solicited

October 16, 1987

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

DCCP Board Approves Concept Of RFA, New, Competing Contracts

October 15, 1982

Celecoxib Effective To Prevent Colon Adenomas, Study Finds

April 25, 2008

Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals

October 10, 2014